Livzon Pharmaceutical Group Inc000513
▼ NegativeCapitalrelevance
Net profit fell 27.23% and revenue dropped 20.28% in the interim report.

Livzon Group released its 2026 interim report, with net profit attributable to the parent company at 932 million yuan, down 27.23% from the same period last year. Total operating revenue was 5 billion yuan, down 20.28% year-on-year. Net cash inflow from operating activities was 1.763 billion yuan. The latest asset-liability ratio was 38.12%, gross margin was 61.28%, ROE was 6.97%, and diluted earnings per share was 1.05 yuan.
Livzon Pharmaceutical Group IncNet profit fell 27.23% and revenue dropped 20.28% in the interim report.